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Background: Protopanaxadiol (PPD) is a triterpenoid that can be prepared from steamed ginseng. PPD possesses
anticancer potential via caspase-dependent apoptosis. Whether paraptosis, a type of the caspase-independent cell
death, is also induced by PPD has not been evaluated.
Methods: Cell death, the cell cycle and intracellular reactive oxygen species (ROS) were analyzed by flow cytometry
after staining with annexin V/PI, PI/RNase or H2DCFDA. We observed morphological changes by crystal violet
staining assay. Mitochondrial swelling was measured by ultraviolet–visible spectrophotometry. The activation of
NF-κB was measured by luciferase reporter assay.
Results: At comparable concentrations of 5-fluorouracil, PPD induced more cell death in human colorectal cancer
cell lines HCT-116 and SW-480. We demonstrated that PPD induced paraptosis in these cancer cells. PPD treatment
significantly increased the percentage of cancer cells with cytoplasmic vacuoles. After the cells were treated with
PPD and cycloheximides, cytoplasmic vacuole generation was inhibited. The paraptotic induction effect of PPD was
also supported by the results of the mitochondrial swelling assay. PPD induced ROS production in cancer cells,
which activated the NF-κB pathway. Blockage of ROS by NAC or PS-1145 inhibited the activation of NF-κB signaling.
Conclusions: PPD induces colorectal cancer cell death in part by induction of paraptosis. The anticancer activity of
PPD may be enhanced by antioxidants such as green tea, which also inhibit the activation of NF-κB signaling.
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Cancer chemopreventionBackground
The clinical management of cancer invariably involves
diverse conventional modalities, including surgery, radia-
tion, and chemotherapy [1]. Because of the complexity
of human cancer, alternative management may be nee-
ded to improve the efficacy of therapeutic treatments
and the quality of life of patients [2]. Cancer chemo-
prevention or treatment may combine natural products
with chemotherapeutic agents to inhibit tumor develop-
ment [3-5]. Natural products have been shown to be one* Correspondence: CYuan@dacc.uchicago.edu
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reproduction in any medium, provided the oroption for cancer chemoprevention and new drug deve-
lopment [6-8].
Long-term consumption of certain botanicals, such as
ginseng, is associated with a reduction in cancer inci-
dence in humans [9,10]. Anticancer potential has been
observed with ginseng and its compounds, including the
enhancement of 5-fluoruracil’s anti-proliferative effects
on human cancer cells [11-13]. Steaming ginseng changes
its ginsenoside profile and increases its anticancer poten-
tial [14,15].
The ginsenoside Rh2 in ginseng induced apoptosis and
paraptosis-like cell death in colon cancer cells [16]. Gin-
senoside Rh2 levels are low in untreated ginseng, but
after steaming, Rh2 levels increase [17]. In a recent review
of the relationship between the structure and function oftd. This is an Open Access article distributed under the terms of the Creative
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in ginsenosides increases their anticancer bioactivity [7].
We also observed that further heat treatment of ginseng
initiated the conversion of Rh2 to protopanaxadiol (PPD).
In this transformation, another sugar molecule is removed
from Rh2 (see Discussion and Figure 1).
PPD possesses anticancer potential because it induces
cell apoptosis, a programmed cell death that is caspase-
dependent [18]. Paraptosis, another type of cell death, is
characterized by the accumulation of cytoplasmic vacuoles
and mitochondrial swelling [19]. Whether PPD-induced
cell death also is mediated by caspase-independent para-
ptosis, like Rh2, is not known. In previous studies, Rh2
increased levels of reactive oxygen species (ROS) and acti-
vated the NF-κB survival pathway [16]. It would be inter-
esting to know whether ROS blockage and inhibition of
NF-κB signaling increases PPD-induced cell death and
whether PPD’s effect is enhanced by antioxidants becauseFigure 1 Transformation pathways of panaxadiol group ginsenosides
During steaming, ginsenosides Rb1, Rc and Rd are mainly transformed to R
intestinal microbiota metabolize Rb1, Rc and Rd to compound K, which caantioxidant dietary supplements are often self-administered
by cancer patients [20,21]. The present study data suggest




DMSO and other solvents were obtained from Fisher Sci-
entific (Pittsburgh, PA). Trypsin, McCoy’s 5A, Leibovitz’s
L-15 medium, fetal bovine serum (FBS), and penicillin/
streptomycin solution (200×) were obtained from Media-
tech, Inc. (Herndon, VA). N-Acetyl-L-cysteine (NAC), PS-
1145, propidium iodide (PI) and RNase were obtained
from Sigma (St. Louis, MO). NAC, which is an antio-
xidant, was dissolved in the growth medium. PS-1145, a
specific inhibitor of the NF-κB pathway, was dissolved
in DMSO as a 20 mM stock buffer. Protopanaxadiol
(PPD) was obtained from National Institutes for FoodRb1, Rc and Rd by steaming treatment and intestinal microbiota.
g5, Rk1, and Rg3. Rg3 then converts to Rh2 and PPD. In addition,
n be further converted to PPD (dotted lines).
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was obtained from American Pharmaceutical Partners
Inc. (Schaumburg, IL). Luciferase assay kits were obtained
from Promega (Madison, WI). Annexin V Apoptosis Kit
was purchased from BD Biosciences (San Diego, CA). Re-
active oxygen species (ROS) dye 20,70-dichlorodihydro-
fluorescein diacetate (H2DCFDA) and L-glutamine were
obtained from Invitrogen (Carlsbad, CA).
Cell culture
Human colorectal cancer cells HCT-116 and SW-480
were obtained from the American Type Culture Collec-
tion (ATCC, Manassas, VA), and were maintained in
McCoy’s 5A (HCT-116) or Leibovitz’s L-15 (SW-480)
medium supplemented with 5% fetal bovine serum, 50 IU
of penicillin/streptomycin and 2 mmol/L of L-glutamine
in a humidified atmosphere with 5% CO2 at 37°C.
Cell death assay
Cells were seeded into 24-well plates (2 × 105 cells/well).
Samples were prepared based on the instruction pro-
vided with the Annexin V Apoptosis Kit. Briefly, after
treatment as indicated in the result section, the adhe-
rent and detached cells were collected and washed twice
with binding buffer containing 10 mM HEPES, pH 7.4,
140 mM NaCl, 2.5 mM CaCl, and then 1 × 105 cells were
resuspended in 100 μl of binding buffer. 5 μl of annexin
V-FITC and 10 μl of propidium iodide (50 μg/ml, stocking
concentration) were added to the cell suspension. After
gently mixing, the cells were incubated for 15 min at
room temperature, and then 400 μl of binding buffer
was added to get the sample ready. Quantification of
cell death was performed using a FACScan flow cytome-
ter (BD Biosciences, San Jose, CA). All the data analyses
were performed using FlowJo analysis software, version
6.0 (FlowJo LLC, Ashland, OR). Annexin V-positive and/
or PI-positive cells were considered as cell death.
Cell cycle analysis
Cells were seeded in 24-well plates (2 × 105 cells/well).
After 48 h of drug exposure or control conditions, cells
were fixed gently by adding 80% ethanol before they were
placed in a freezer for 2 h; then cells were treated with
0.25% Triton X-100 for 5 min in an ice bath. The cells
were resuspended in 130 μl of PBS. Then, 5 μl of PI/
RNase staining solution was added to the cell suspen-
sion. Cells were incubated in a dark room for 10 min
at room temperature and analyzed using a FACScan flow
cytometer.
Crystal violet staining assay
HCT-116 cells were seeded in 24-well plates (1 × 105 cells/
well). After 12 h of drug exposure or control conditions,
the medium was removed and the cells were washed andstained with 0.2% crystal violet in 10% phosphate-buffered
formaldehyde for 2 min. The staining solution was remo-
ved and the cells were washed twice with PBS. The re-
maining cells adhering to the wells were observed under
the microscope and photographed.Mitochondrial swelling assay
Human liver mitochondria were obtained from Xeno-
tech LLC (Lenexa, KS). Before the experiment, the mito-
chondria were suspended in 230 mM mannitol, 70 mM
sucrose, 10 mM Tris–HCl, and 1 mM EDTA, with a
protein concentration of 0.5 mg/ml. After exposure to
35 μM of PPD or control condition at 25°C, mitochon-
drial swelling was measured by the ultraviolet–visible
spectrophotometry method. The absorbance changes at
540 nm were monitored [22].Intracellular ROS assay
Intracellular ROS production was monitored by the per-
meable fluorescence dye, H2DCFDA. H2DCFDA can rea-
dily react with ROS to form the fluorescent product
2,7-dichlorofluorescein (DCF). The intracellular fluores-
cence intensity of DCF is proportional to the amount of
ROS generated by the cells. After the indicated treatment,
the cells were incubated with 10 μM of H2DCFDA for
thirty minutes and then cells were harvested and resus-
pended in PBS (106 cells/mL). The fluorescence intensity
of intracellular DCF (excitation 488 nm, emission 530 nm)
was measured using a FACScan flow cytometer.Luciferase activity assay
The plasmids containing the luciferase reporter gene with
or without a NF-κB response element and phRL-TK plas-
mid for the transfection control were donated by Liao’s
lab (Ben May Department for Cancer Research, University
of Chicago). 104 cells were seeded into 48-well plates for
24 h and were co-transfected with 0.5 μg of plasmid con-
taining report construct and 10 ng of phRL-TK using
transfection reagent Effectene (Qiagen, Chatsworth, CA).
At 24 h post-transfection, the cells were treated as de-
sired. Luciferase activity was measured with a commercial
kit (Promega Dual luciferase II) on a Monolight lumin-
ometer (Becton Dickinson, Franklin Lakes, NJ).Statistical analysis
All experiments were performed in triplicate. The data
are presented as mean ± standard error (SE). A one-way
ANOVA determined whether the results had statistical
significance. In some cases, a Student’s t-test was used
for comparing two groups. The level of statistical signifi-
cance was set at P < 0.05.
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Effects of PPD on cell death and cell cycle of human
colorectal cancer cells
We used two human colorectal cancer cell lines, HCT-
116 and SW-480, to evaluate the effect of PPD on induc-
tion of cell death. As shown in Figure 2, for HCT-116
cells, treatment with 30, 35 and 40 μM of PPD for 48 h
induced 20.9 ± 1.7%, 50.4 ± 3.9% and 74.2 ± 3.4% cell
death, respectively (all P < 0.01 vs. control, 6.5 ± 1.5%). Si-
milar effects were observed in SW-480 cells (Figure 2A).
PPD significantly induced cell death in both of the cell
lines in a concentration-dependent manner. As a positive
control, we also tested the effect of 5-FU, a commonly
used chemotherapeutic agent against colorectal cancer, on
the induction of cell death (Figure 2B). The data show
that, when comparable concentrations were used, the ef-
fect of PPD was stronger than that of 5-FU, suggesting
that PPD could be a potential colorectal cancer chemopre-
ventive compound.
PPD’s effect on the cancer cell cycle is illustrated in
Figure 3. Compared to control (G1 36.1%, S 33.4% and
G2/M 25.1% for HCT-116; G1 47.2%, S 28.5% and G2/
M 16.9% for SW-480), 10 and 20 μM of PPD did not
change the cell cycle profile. Treatment with 30 μM of
PPD for 48 h changed the cell cycle profile, with G1
55.8%, S 18.9% and G2/M 14.8% for HCT-116 cells; G1
62.2%, S 11.8% and G2/M 14.5% for SW-480. In both
HCT-116 and SW-480 cells, PPD obviously increased
cell fractions in the G1 phase.
PPD-induced paraptosis-like cell death
To explore the potential mechanism through which PPD
induced cell death, morphological observation was con-
ducted after crystal violet staining. As shown in Figure 4A,
after treatment with 35 μM of PPD for 24 h, cytoplasmic
vacuolization was significant. HCT-116 cells treated with
vehicle control did not show vacuoles. When the PPD
concentration was increased, the fraction of cells with


























Figure 2 Effects of PPD and 5-FU on cell death in two human colorec
SW-480 cell death. (B) Effects of 5-FU (10–100 μM) on HCT-116 and SW-480
after 48 h treatment. Data are presented as the mean ± standard error. *P <cytoplasmic vacuolization is a typical feature of paraptosis.
Induction of paraptosis requires new protein synthesis
but resists inhibition by caspase inhibitors. Pre-treatment
of HCT-116 cells with cycloheximide (Cyclo), a protein
synthesis inhibitor, blocked PPD-induced vacuole forma-
tion (Figure 4A). In addition to the formation of vacuoles
in the cytoplasm, paraptosis is also characterized by mito-
chondrial swelling [8]. As illustrated in Figure 4C, PPD
significantly induced mitochondrial swelling by monitor-
ing absorbance at 540 nm in isolated human liver mito-
chondria. Thus, PPD induced cancer cell death in part via
paraptosis.Effects of PPD on induction of ROS
We measured ROS levels in colorectal cancer cells after
treatment with PPD to determine if the compound in-
duced ROS. To evaluate time-dependent activity, HCT-
116 cells were treated with 35 μM of PPD, and ROS
levels were measured at different time points. After treat-
ment with PPD for 6 h, ROS level was significantly higher
than in the control. Thus, the 6 h time point was cho-
sen (Figure 5A). Using two cell lines, HCT-116 and
SW-480, ROS levels were determined after treatment
with 20–40 μM of PPD. As shown in Figure 5B and
5C, PPD significantly induced ROS production at 6 h
in a concentration-dependent manner in both cell lines.
These results suggest that PPD induced ROS production
in human colorectal cancer cells.PPD activated the NF-κB pathway linked to ROS
generation
Ginseng-induced ROS promotes cell survival in colorec-
tal cancer cells via activation of the NF-κB pathway. To
determine whether PPD-induced ROS also activates the
NF-κB pathway, we measured NF-κB reporter activity
after treating HCT-116 cells with PPD. At the same con-
centration that led to high levels of ROS (Figure 5), PPD


























tal cancer cell lines. (A) Effects of PPD (10–50 μM) on HCT-116 and
cell death. Cell death in the presence of PPD or 5-FU was measured
0.05, **P < 0.01 vs. control.







   
   
   




























































Figure 3 Effects of PPD on colorectal cancer cell cycle. HCT-116 and SW-480 cells were treated with 10–30 μM PPD for 48 h, then fixed in
ethanol and stained with propidium iodide. DNA content was determined by flow cytometry. (A) Representative histograms of DNA content in
each experimental group. (B) Percentage of each cell cycle phase with various treatments. Data are presented as the mean ± standard error.
*P < 0.05, **P < 0.01 vs. control.
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NF-κB reporter activity, assuming that increased levels
of ROS are required to induce NF-κB signaling. Addi-
tion of the antioxidant NAC significantly blocked the
PPD-mediated induction of NF-κB transcriptional acti-
vity (Figure 6B) and increased cell death in HCT-116
cells, suggesting that PPD-induced ROS contribute to
the activation of the NF-κB pathway.
We expected that the activated NF-κB pathway would
counteract PPD-induced cell death in colorectal cancer
cells because a decrease in ROS decreases NF-κB trans-
criptional activity. To further test the relationship of
PPD-induced NF-κB activation and cell death, we inhibi-
ted the NF-κB pathway by adding PS-1145, a specific in-
hibitor of the NF-κB pathway, to PPD-treated HCT-116
cells. PS-1145 significantly inhibited both basal and
PPD-induced NF-κB transcriptional activity (Figure 6C),
and increased PPD-induced cell death in HCT-116 cells.
PPD-induced ROS contributed to the survival of colo-
rectal cancer cells via activation of the NF-κB pathway.
Therefore, PPD-induced colorectal cancer cell death is
enhanced by antioxidants or an NF-κB inhibitor.Discussion
After several years of cultivation in China or Korea, the
root of Asian ginseng is harvested and steamed at stan-
dard boiling temperature; the steamed root is called red
ginseng. It is believed that the steaming changes the ginse-
noside composition profile, improving pharmacological
activities. Our group used controlled variable steaming pa-
rameters to treat American ginseng and notoginseng to
obtain desired ginsenoside profiles for increasing cancer
chemopreventive effects [14,15].
American ginseng is a commonly used dietary sup-
plement in United States. The major ginsenosides in
American ginseng belong to the protopanaxadiol group
and include Rb1, Rc and Rd [23]. Ginsenoside Rb1 is the
most abundant ginsenoside in American ginseng, accoun-
ting for over 50% of total ginsenosides in many samples.
Figure 1 elucidates the ginsenoside transformation by
steaming treatment and intestinal microbiota. During
steaming treatment, the protopanaxadiol group of gin-
senosides are mainly transformed via three pathways:
1) to Rg5 and then to Rh4; 2) to Rk1 and then to
Rk3; and 3) a major route, to Rg3, Rh2, and then to





































































Figure 5 Effects of PPD on the induction of ROS on colorectal cancer cells. (A) HCT-116 cells were treated with 35 μM of PPD, and then
ROS level was measured at different time points. (B) HCT-116 cells were treated with different concentrations of PPD for 6 h, and then ROS level
was determined. (C) SW-480 cells were treated with different concentrations of PPD for 6 h, and then ROS level was determined. Data are




































































Figure 4 Induction of PPD on paraptosis-like cell death. (A) HCT-116 cells were treated with 10–35 μM of PPD in combination with or
without 10 μg/ml of cycloheximide (Cyclo) for 24 h, and then pictured. (B) The percentage of cytoplasmic vacuoles with 10–35 μM of PPD.
(C) Mitochondrial swelling induced by 35 μM of PPD observed by monitoring absorbance at 540 nm in isolated human liver mitochondria.
Data are presented as the mean ± standard error. *P < 0.05, **P < 0.01 vs. control.
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Figure 6 PPD activated the NF-κB pathway via ROS generation. (A) 24 h after transient transfection of NF-κB reporter plasmids, HCT-116 cells
were treated with different concentrations of PPD for 24 h before the luciferase reporter activity was determined. (B) HCT-116 cells were treated
with 35 μM of PPD for 24 h in the presence or absence of NAC (10 mM). (C) HCT-116 cells were treated with 35 μM of PPD for 24 h in the
presence or absence of PS-1145 (50 μM). Data are presented as the mean ± standard error. **P < 0.01 vs. control; ##P < 0.01 vs. PPD only.
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tration, gut microbiota, which normally exist in the
gastrointestinal tract, can convert Rb1 and other pro-
topanaxadiol group ginsenosides into their metabolite,
ginsenoside compound K (CK) [25,26]. Recently, our stu-
dy data showed that a relatively high amount of CK could
be transformed to PPD by gut microbiota (unpublished
data). Thus, the evaluation of cancer chemopreventive ef-
fects of PPD and its related mechanism of action is par-
ticularly pertinent to ginseng anticancer investigations.
Two representative human cancer cell lines, HCT-116
and SW-480, which differ in the expression of the p53
tumor suppressor gene, were used in our cell death ob-
servation. HCT-116 is p53 wild-type, while SW-480 has
mutated p53. Tumor suppressor gene p53 is thought to
be important in the cellular response to chemothera-
peutic agent-induced damage. Mutation in p53 has been
shown to correlate with an increased resistance to che-
motherapy in cancer cells [27]. Our results showed that
PPD significantly induced cell death in these two cell lines
in a concentration-dependent manner, and HCT-116 was
more sensitive even at lower concentrations. After PPD
treatment, accumulation of cytoplasmic vacuoles was ob-
served in the cancer cells, suggesting that paraptosis,
another type of programmed cell death [19], was associated
with PPD’s effect. Paraptosis is further supported by a mito-
chondrial swelling assay and by the observation that PPD
used in combination with cycloheximides, a protein synthe-
sis inhibitor, blocked PPD-induced vacuole formation.
5-Fluorouracil (5-FU) is a chemotherapeutic agent
widely used for cancers of different organs including col-
orectum [28]. The clinical response rate of 5-FU in colo-
rectal cancer treatment was 20-30%, and in combination
with irinotecan or oxaliplatin, up to 50% [29,30]. Con-
sistent with others [31], we observed that the cell deathinduction of 5-FU is not very impressive, with apoptosis
as a main cellular response to treatment with 5-FU. At
comparable concentrations, our data showed that PPD
more significantly induced cell death. It is crucial for fu-
ture work to identify combinatory therapies of natural
product-derived compounds to increase the effectiveness
of 5-FU on human colorectal cancer.
Our data showed that in both tested colon cancer cell
lines, PPD significantly induced ROS production. Fur-
ther, PPD activated the NF-κB pathway, which is linked
to ROS generation. When the antioxidant NAC was used,
NF-κB reporter activity levels were significantly reduced.
This observation suggested that co-administration of PPD
and a botanical antioxidant may achieve better cancer
chemopreventive effects. Panaxadiol (PD) is a purified
sapogenin of ginseng saponins, which has exhibited sig-
nificant anticancer activity [11]. Structurally, PD is very
similar to PPD, with basically only side chain cyclization
[23]. Epigallocatechin gallate (EGCG), a major catechin in
green tea, is a strong botanical antioxidant. Recently, we
reported synergistic anticancer effects of PD and EGCG
[32]. Based on the similar chemical structure of PD and
PPD, it would be expected that co-administration of PPD
and EGCG could also initiate increased cancer chemopre-
vention activities.Conclusions
Results from the present study suggest that paraptosis
and NF-κB activation are associated with PPD-induced
cancer chemoprevention. The activation of PPD’s NF-κB
pathway is linked to its increased ROS level.Competing interests
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